Drug-induced liver diseases

被引:140
作者
Larrey, D [1 ]
机构
[1] Hop St Eloi, Serv Hepatogastroenterol & Transplantat Hepat, Montpellier, France
关键词
drug-induced hepatotoxicity; herbal medicines;
D O I
10.1016/S0168-8278(00)80417-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced liver injuries make up a persisting and challenging problem for physicians, health agencies and pharmaceutical firms. The clinical expression is polymorphous, acute hepatitis being predominant. The diagnosis is frequently difficult because of the absence of specific signs in most cases and mainly relies on the exclusion of other causes. The diagnosis should be particularly evoked in patients over 50 yr who are taking many drugs, after viral infections have been ruled out. Acute hepatocellular hepatitis is particularly severe because of the risk of fulminant hepatitis or of a more insidious course leading to cirrhosis, Cross hepatotoxicity can sometimes occur. One should avoid re-administration of not only the causative agents but also of other drugs belonging to the same family or having a related chemical structure. The prediction of the hepatotoxicity of new drugs must be improved. Investigations would be particularly useful for drugs having critical chemical structures and belonging to families with an established history of hepatotoxicity.
引用
收藏
页码:77 / 88
页数:12
相关论文
共 52 条
[1]   Hepatotoxicity in drug development: Detection, significance and solutions [J].
Ballet, F .
JOURNAL OF HEPATOLOGY, 1997, 26 :26-36
[2]   HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES APPEARING IN A DRUG-INDUCED HEPATITIS ARE DIRECTED AGAINST A HUMAN-LIVER CYTOCHROME-P-450 THAT HYDROXYLATES THE DRUG [J].
BEAUNE, P ;
DANSETTE, PM ;
MANSUY, D ;
KIFFEL, L ;
FINCK, M ;
AMAR, C ;
LEROUX, JP ;
HOMBERG, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :551-555
[3]  
BENICHOU C, 1990, J HEPATOL, V11, P272
[4]  
BERNUAU J, 1999, OXFORD TXB CLIN HEPA, V2, P1341
[5]   POSSIBLE ROLE OF HLA IN HEPATOTOXICITY - AN EXPLORATORY-STUDY IN 71 PATIENTS WITH DRUG-INDUCED IDIOSYNCRATIC HEPATITIS [J].
BERSON, A ;
FRENEAUX, E ;
LARREY, D ;
LEPAGE, V ;
DOUAY, C ;
MALLET, C ;
FROMENTRY, B ;
BENHAMOU, JP ;
PESSAYRE, D .
JOURNAL OF HEPATOLOGY, 1994, 20 (03) :336-342
[6]  
BIOUR M, GASTROENTEROL CLIN B, V22, P1004
[7]   Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis [J].
Bourdi, M ;
Chen, WQ ;
Peter, RM ;
Martin, JL ;
Buters, JTM ;
Nelson, SD ;
Pohl, LR .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (07) :1159-1166
[8]   ANTI-LIVER ENDOPLASMIC-RETICULUM AUTOANTIBODIES ARE DIRECTED AGAINST HUMAN CYTOCHROME-P-4501A2 - A SPECIFIC MARKER OF DIHYDRALAZINE-INDUCED HEPATITIS [J].
BOURDI, M ;
LARREY, D ;
NATAF, J ;
BERNUAU, J ;
PESSAYRE, D ;
IWASAKI, M ;
GUENGERICH, FP ;
BEAUNE, PH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1967-1973
[9]   Drug-induced immunotoxicity [J].
Dansette, PM ;
Bonierbale, E ;
Minoletti, C ;
Beaune, PH ;
Pessayre, D ;
Mansuy, D .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (04) :443-451
[10]  
De Sousa M, 1998, PHARMACOGENETICS, V8, P353